A Case Study on National List of Essential Medicines(NLEM)in India and WHO EML 2015-Overview

  • Bandameedi R
  • Mohammed S
N/ACitations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Availability of modern medicine increased all over the world due to huge expansion of the global Pharma market. At the same time misuse as well as accessibility of the most of essential drugs to majority of the population was denied due to cost-effectiveness of healthcare delivery combined with poor procurement policies and poor prescribing practices. During the recent years, the national list of India has assumed immense importance to improve access to medicines in India. It is therefore necessary to understand policies and guidelines followed in developing WHO essential drug list and national list of essential medicines. In this review article history of essential drug list and important inclusions in NLEM 2015 and WHO EML 2015 were highlighted.

Cite

CITATION STYLE

APA

Bandameedi, R., & Mohammed, S. (2016). A Case Study on National List of Essential Medicines(NLEM)in India and WHO EML 2015-Overview. Pharmaceutical Regulatory Affairs: Open Access, 05(01). https://doi.org/10.4172/2167-7689.1000159

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free